EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges

Cristina R Hofman, David R Corey

Cell Chemical Biology · 2024-01 · 31 (1) · 125-138

DOI: 10.1016/j.chembiol.2023.09.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Chemical Biology, 2024-01. Verfasst von Cristina R Hofman und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Departments of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390-9041, USA. Hauptthemen laut MEDLINE: RNA, Oligonucleotides. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Welch Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic antisense oligonucleotides (ASOs) and duplex RNAs (dsRNAs) are an increasingly successful strategy for drug development. After a slow start, the pace of success has accelerated since the approval of Spinraza (nusinersen) in 2016 with several drug approvals. These accomplishments have been achieved even though oligonucleotides are large, negatively charged, and have little resemblance to traditional small-molecule drugs-a remarkable achievement of basic and applied science. The goal of this review is to summarize the foundation underlying recent progress and describe ongoing research programs that may increase the scope and impact of oligonucleotide therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNAOligonucleotidesOligonucleotides, AntisenseDrug Development

Substanzen

RNAOligonucleotidesOligonucleotides, Antisense

Autor:innen und Institutionen

  • The Departments of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390-9041, USA.
  • The Departments of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390-9041, USA. Electronic address: david.corey@utsouthwestern.edu.

Förderung

  • NIGMS NIH HHS
  • Welch Foundation
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Hofman, C. R., & Corey, D. R. (2024). Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges. Cell Chemical Biology, 31(1), 125-138. https://doi.org/10.1016/j.chembiol.2023.09.005

Vancouver

Hofman CR, Corey DR. Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges. Cell Chemical Biology. 2024;31(1):125-138. doi:10.1016/j.chembiol.2023.09.005

BibTeX
@article{Hofman2024,
  author = {Hofman, Cristina R and Corey, David R},
  title = {Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges},
  journal = {Cell Chemical Biology},
  year = {2024},
  volume = {31},
  number = {1},
  pages = {125--138},
  doi = {10.1016/j.chembiol.2023.09.005}
}
Kostenlos starten →